325 related articles for article (PubMed ID: 30462233)
1. Association between atrial fibrillation and patient-important outcomes in heart failure patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis.
Naka KK; Bazoukis G; Bechlioulis A; Korantzopoulos P; Michalis LK; Ntzani EE
Eur Heart J Qual Care Clin Outcomes; 2019 Apr; 5(2):96-104. PubMed ID: 30462233
[TBL] [Abstract][Full Text] [Related]
2. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality.
Bunch TJ; Day JD; Olshansky B; Stolen KQ; Mullin CM;
Heart Rhythm; 2009 Jan; 6(1):2-8. PubMed ID: 18996055
[TBL] [Abstract][Full Text] [Related]
3. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
[TBL] [Abstract][Full Text] [Related]
4. Impact of Implantable Cardioverter-Defibrillator Interventions on All-Cause Mortality in Heart Failure Patients: A Meta-Analysis.
Bazoukis G; Tse G; Korantzopoulos P; Liu T; Letsas KP; Stavrakis S; Naka KK
Cardiol Rev; 2019; 27(3):160-166. PubMed ID: 30052536
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation is a marker of increased mortality risk in nonischemic heart failure-Results from the DANISH trial.
Boas R; Thune JJ; Pehrson S; Køber L; Nielsen JC; Videbæk L; Haarbo J; Korup E; Bruun NE; Brandes A; Eiskjær H; Thøgersen AM; Philbert BT; Svendsen JH; Dixen U
Am Heart J; 2021 Feb; 232():61-70. PubMed ID: 33144085
[TBL] [Abstract][Full Text] [Related]
6. Predicting Survival in Patients With Heart Failure With an Implantable Cardioverter Defibrillator: The Heart Failure Meta-Score.
Alba AC; Walter SD; Guyatt GH; Levy WC; Fang J; Ross HJ; Lee DS
J Card Fail; 2018 Nov; 24(11):735-745. PubMed ID: 29175281
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
[TBL] [Abstract][Full Text] [Related]
8. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
Borleffs CJ; van Rees JB; van Welsenes GH; van der Velde ET; van Erven L; Bax JJ; Schalij MJ
J Am Coll Cardiol; 2010 Mar; 55(9):879-85. PubMed ID: 20185038
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis.
Rattanawong P; Upala S; Riangwiwat T; Jaruvongvanich V; Sanguankeo A; Vutthikraivit W; Chung EH
J Interv Card Electrophysiol; 2018 Mar; 51(2):91-104. PubMed ID: 29332241
[TBL] [Abstract][Full Text] [Related]
10. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
[TBL] [Abstract][Full Text] [Related]
11. Predictors of mortality in patients with an implantable cardiac defibrillator: a systematic review and meta-analysis.
Alba AC; Braga J; Gewarges M; Walter SD; Guyatt GH; Ross HJ
Can J Cardiol; 2013 Dec; 29(12):1729-40. PubMed ID: 24267811
[TBL] [Abstract][Full Text] [Related]
12. Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis.
Mustafa U; Dherange P; Reddy R; DeVillier J; Chong J; Ihsan A; Jones R; Duddyala N; Reddy P; Dominic P
J Am Heart Assoc; 2018 Nov; 7(22):e010156. PubMed ID: 30554547
[TBL] [Abstract][Full Text] [Related]
13. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
[TBL] [Abstract][Full Text] [Related]
14. Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
Maruyama M; Yasuoka R; Nagano T; Nakazawa G; Noda T; Nitta T; Aizawa Y; Ohe T; Kurita T
J Cardiol; 2021 Sep; 78(3):244-249. PubMed ID: 33941429
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure.
Desai H; Aronow WS; Ahn C; Gandhi K; Hussain S; Lai HM; Sharma M; Frishman WH; Cohen M; Sorbera C
Am J Cardiol; 2010 May; 105(9):1336-8. PubMed ID: 20403488
[TBL] [Abstract][Full Text] [Related]
16. Clinical factors associated with baseline history of atrial fibrillation and subsequent clinical outcomes following initial implantable cardioverter-defibrillator placement.
Giancaterino S; Nishimura M; Birgersdotter-Green U; Hoffmayer KS; Han FT; Raissi F; Ho G; Krummen D; Feld GK; Hsu JC
Pacing Clin Electrophysiol; 2020 Jun; 43(6):542-550. PubMed ID: 32297348
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis.
Elkaryoni A; Badarin FA; Khan MS; Ellakany K; Potturi N; Poonia J; Kennedy KF; Magalski A; Sperry BW; Wimmer AP
Europace; 2019 Sep; 21(9):1353-1359. PubMed ID: 31086951
[TBL] [Abstract][Full Text] [Related]
18. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
19. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
